z-logo
open-access-imgOpen Access
Glucagon receptor family in GtoPdb v.2021.3
Author(s) -
D. Bataille,
Susan L.F. Chan,
Philippe Delagrange,
Daniel J. Drucker,
Burkhard Göke,
Rebecca Hills,
Kelly E. Mayo,
Laurence J. Miller,
Roberto Salvatori,
Bernard Thorens
Publication year - 2021
Publication title -
iuphar/bps guide to pharmacology cite
Language(s) - English
Resource type - Journals
ISSN - 2633-1020
DOI - 10.2218/gtopdb/f29/2021.3
Subject(s) - glucagon , secretin family , secretin , receptor , endocrinology , medicine , glucagon like peptide 1 , peptide hormone , hormone , peptide , chemistry , biology , secretion , vasoactive intestinal peptide , biochemistry , neuropeptide , diabetes mellitus , type 2 diabetes
The glucagon family of receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on the Glucagon receptor family [162]) are activated by the endogenous peptide (27-44 aa) hormones glucagon, glucagon-like peptide 1, glucagon-like peptide 2, glucose-dependent insulinotropic polypeptide (also known as gastric inhibitory polypeptide), GHRH and secretin. One common precursor (GCG) generates glucagon, glucagon-like peptide 1 and glucagon-like peptide 2 peptides [119]. For a recent review on the current understanding of the structures of GLP-1 and GLP-1R, the molecular basis of their interaction, and the associated signaling events see de Graaf et al., 2016 [89].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom